Interestingly, a polymorphism in the TNF gene itself, which results in higher plasma levels of TNFα, has been shown to corelate with poor outcomes in a number of hematologic malignancies, including Hodgkin’s[72] and non-Hodgkin’s lymphoma[73]. Here, TNF is linked to non-Hodgkin lymphoma.